Huntington Ingalls Industries Inc Stock Prediction and Forecast [HII]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 23 Dec 2025, 04:26 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for Huntington Ingalls Industries Inc Stock Prediction and Forecast [HII]](https://i.ytimg.com/vi/38DAqxh6LjM/hqdefault.jpg)
AI-generated source summary
Huntington Ingalls Industries Inc. (HII) exhibits several positive signals, particularly in its recent upward price momentum driven by positive earnings estimate revisions and strong contract news. The stock has broken through its upward trend, with its 50-day and 200-day moving averages indicating bullishness. Volume has also been above average, signaling increased investor interest. Key technical levels to watch include a potential resistance at $351.21 for short-term trades and a projected peak around $384.81 in the long term. Support is identified at $336.64, with a failure below this level potentially invalidating the bullish outlook. Analyst ratings are predominantly positive, with a consensus 'Buy' recommendation.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.